To include your compound in the COVID-19 Resource Center, submit it here.

Genzyme Transgenics to re-acquire rhATIII rights

GZTC signed a letter of intent to re-acquire rights in Europe and

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE